retatrutide weight loss clinical trial results VisualAbstract: reduces body by 17.5% in patients with obesity What the clinical trials say

The Danish pharma group lost no time in slamming Hims & Hers' move, saying it deplores the plan to "unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill." In a statement, it said: "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety

& Billiar, T

Nature Reviews Molecular Cell Biology

Diabetes 47 , 12531258 (1998)

By submitting this form, you agree to receive email, phone and text messages from Sono Bello related to our services, including via automated dialing technology and pre-recorded voice messages

GLP-1 microdosing involves using precisely calibrated smaller doses that maintain therapeutic effectiveness while dramatically reducing unwanted side effects